Genflow biosciences plc announces result of agm

London, united kingdom / accesswire / june 27, 2024 / genflow biosciences plc (lse:genf)(otcqb:genff) ("genflow" or "the company") an emerging leader in the field of longevity research, focused on developing therapeutic solutions for the prevention of age-related diseases is pleased to announce that all resolutions proposed at the annual general meeting held earlier today were duly passed. contacts genflow biosciences harbor access dr eric leire, ceo jonathan paterson, investor relations +32-477-495-881 +1 475 477 9401 jonathan.paterson@harbor-access.com capital plus partners ltd keith swann, +44 0203 821 6169 jon critchley, +44 0203 821 6168 about genflow founded in 2020, genflow biosciences plc.
AGMH Ratings Summary
AGMH Quant Ranking